معرفی
Herbert Yu, MD, PhD, is an Adjunct Professor at Yale School of Public Health's Department of Chronic Disease Epidemiology. With over 20 years of cancer research experience, he specializes in molecular epidemiology focusing on gene-environment interactions and epigenetic regulation in cancer development. His research spans breast, ovarian, pancreatic, liver, and uterine cancers.
Education:
- PhD, University of Toronto (1996)
- MSc, University of Toronto (1990)
- MD, Shanghai Medical University (1983)
Research focuses on:
- Molecular characterization of insulin-like growth factors in breast/ovarian cancers
- DNA methylation in cancer risk stratification
- GWAS studies on endometrial cancer
- Development of non-invasive cancer biomarkers
Publication analysis reveals predominant focus on:
- Cancer biomarker discovery (50%)
- AI/ML applications in oncology (20%)
- Molecular pathway analysis (20%)
- Epidemiological risk modeling (10%)
Awards and Honors:
- Wang Fellowship for International Study of Public Health
- American Association for Clinical Chemistry Young Investigator Award
- Mitchell Scholarship in Cancer Research
- International Scholar Award in Breast Cancer Research
Research leadership includes principal investigator roles on NIH-funded projects including a multimillion-dollar grant for liver cancer research. Collaborates extensively with Yale Cancer Center researchers on molecular oncology studies.
۰مقاله منتشرشده
